FINWIRES · TerminalLIVE
FINWIRES

ASX:MPL

3 stories mentioning ASX:MPLUpdated 31d ago

Every FINWIRES story that references ASX:MPL, newest first.

Asia

ASX Most Active Stocks

Here are the five most actively traded big-cap stocks on the Australian Securities Exchange on Friday.Arafura Rare Earths (ASX:ARU): 18.3 million sharesLiontown (ASX:LTR): 9.6 million sharesMedibank Private (ASX:MPL): 9.4 million sharesDroneShield (ASX:DRO): 8.2 million sharesPLS Group (ASX:PLS): 7.2 million shares

ASX 200ASX:ARUASX:DROASX:LTRASX:MPLASX:PLS
Asia

Medibank Private Expected to Meet Fiscal Year 2026 Outlook, Jefferies Says

Medibank Private (ASX:MPL) is expected to meet its fiscal year 2026 outlook, given that policyholder growth is typically highest in the fiscal fourth quarter, Jefferies said in a note on Tuesday.Its resident policyholder growth of 2.3% in the twelve months to December 2025, outpacing industry growth of 2.1%, implies market share gain even with heightened competition.The fiscal third quarter claims growth was consistent with the industry, and Medibank paid AU$39.3 million to private hospitals under partnership initiatives over the nine months of the fiscal year, compared with AU$36.6 million in fiscal 2025.Its claims growth was consistent with recent industry trends, with some benefit from proactive claims management. It guided to fiscal year 2026 claims per policy unit of 2.6% to 2.9% on the prior corresponding period.The investment firm retained the hold rating on Medibank and raised the price target to AU$5.15 from AU$4.90.

ASX:MPL
Asia

Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook

Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.

ASX:MPL

Track with the FINWIRES app suite